CPH:AMBU B — Ambu A/S - Capital Markets Day
Sep 30, 2025, 10:00:00 PM UTC
Summary
Ambu A/S will host a Capital Markets Day on October 1, 2025, in Ballerup, Denmark, to discuss future strategies and investor relations. The event follows the company's recent announcement of strong financial performance, with an 11.7% organic revenue growth and a 14.4% EBIT margin in the second quarter of the 2024/25 fiscal year. Ambu's positive growth trajectory was driven by increased demand in its Endoscopy Solutions and Anaesthesia & Patient Monitoring sectors. The company maintains its financial guidance for the year, expecting organic growth of 11-14% and EBIT margins of 13-15%.
Company
Ambu (CPH:AMBU B)CPH — Health Care,
Similar Events
Alleima AB Capital Markets Day
Alleima AB will hold its Capital Markets Day on November 5, 2025, at Vasamuseet in Stockholm. The event is set to begin at approximately 13:00 CEST and will feature presentations from the CEO, CFO, and other members of the executive management team. Livestreaming of the event will be available. This event aims to provide institutional investors, analysts, and financial media with updates on Alleima's performance and strategy. Alleima is a global manufacturer specializing in high-value-added products in advanced stainless steel, special alloys, and industrial heating solutions, with annual revenues of approximately 20 billion SEK in 2024.
Capital Markets DayZealand Pharma A/S - Capital Markets Day in London
Zealand Pharma A/S will host a Capital Markets Day in London on December 11, 2025, where management and external experts will discuss the company's efforts in developing innovative peptide-based medicines, particularly in obesity treatment. Amidst a transformative partnership with Roche for its lead product petrelintide, Zealand Pharma aims to solidify its position in the weight management market. The collaboration involves shared profits and milestone payments, with total deal consideration reaching USD 5.3 billion. The event will provide insights into the company’s financial outlook and ongoing trials, with a focus on how these initiatives may impact future performance.
Investor EventAutoliv Capital Markets Day
Autoliv Inc. will hold a Capital Markets Day on June 4, 2025, to present its strategic initiatives and performance outlook. The company's first-quarter 2025 results highlighted good sales and successful execution of cost reduction programs, with net sales of $2,578 million and a 41% increase in diluted EPS to $2.14. Despite a slight sales decline compared to the previous year, organic sales grew by 2.2%. Autoliv expects continued growth driven by new product launches and a solid balance sheet. The event will provide investors with insights into the company's operational strategy amidst a challenging geopolitical environment.
Investor EventColoplast's Capital Markets Day
Coloplast A/S will host its Capital Markets Day on September 2, 2025, at Clarion Hotel, Copenhagen, from 10:30 to 17:00 CEST. The event invites institutional investors, equity analysts, and media to engage with the management team and learn about the company's new 5-year strategy. The agenda includes a plenary session covering strategic directions and a financial update, followed by breakout sessions focusing on specific business areas such as Chronic Care and Advanced Wound Care. The sessions aim to provide investors with detailed insights into Coloplast's operations and growth strategies.
Investor Event